Ye Ying, Wang Guangdong, Wang Guoyu, Zhuang Juhua, He Saifei, Song Yanan, Ni Jing, Xia Wei, Wang Jiening
Department of Nuclear Medicine, The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Department of Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Front Physiol. 2017 Nov 10;8:789. doi: 10.3389/fphys.2017.00789. eCollection 2017.
Hepatocellular carcinoma (HCC) is a common malignancy associated with a high risk of recurrence and metastasis and a poor prognosis. Here, we examined the involvement of the pseudokinase Tribbles 1 (TRIB1), a scaffold protein associated with several malignancies, in HCC and investigated the underlying mechanisms. TRIB1 was upregulated in HCC tissues and cell lines in correlation with low levels of p53. TRIB1 gain and loss of function experiments indicated that TRIB1 promoted HCC cell viability concomitant with the downregulation of p53, and induced HCC cell migration, invasion, and epithelial-mesenchymal transition. TRIB1 was identified as a target of microRNA-23a (miR-23a), and miR-23a overexpression downregulated TRIB1 and upregulated p53 in HCC cells. Ectopic expression of TRIB1 upregulated β-catenin and its effectors c-myc and MMP-7 in a p53-dependent manner. TRIB1 silencing inhibited tumor growth and promoted apoptosis via a mechanism that would involve the modulation of p53 and β-catenin signaling. The present results indicate that TRIB1 promotes HCC tumorigenesis and invasiveness via a feedback loop that involves the modulation of its expression by miR-23a with the likely downregulation of p53, and suggest the involvement of the β-catenin signaling pathway. These findings suggest potential targets for the treatment of HCC and therefore merit further investigation.
肝细胞癌(HCC)是一种常见的恶性肿瘤,具有高复发和转移风险且预后较差。在此,我们研究了假激酶 Tribbles 1(TRIB1)(一种与多种恶性肿瘤相关的支架蛋白)在 HCC 中的作用,并探讨了其潜在机制。TRIB1 在 HCC 组织和细胞系中上调,且与 p53 水平降低相关。TRIB1 的功能获得和缺失实验表明,TRIB1 促进 HCC 细胞活力,同时伴随 p53 下调,并诱导 HCC 细胞迁移、侵袭及上皮-间质转化。TRIB1 被鉴定为微小 RNA-23a(miR-23a)的靶标,miR-23a 过表达可下调 HCC 细胞中的 TRIB1 并上调 p53。TRIB1 的异位表达以 p53 依赖的方式上调 β-连环蛋白及其效应分子 c-myc 和基质金属蛋白酶-7(MMP-7)。TRIB1 沉默通过一种涉及调节 p53 和 β-连环蛋白信号传导的机制抑制肿瘤生长并促进细胞凋亡。目前的结果表明,TRIB1 通过一个反馈环促进 HCC 的肿瘤发生和侵袭,该反馈环涉及 miR-23a 对其表达的调节以及可能的 p53 下调,并提示 β-连环蛋白信号通路的参与。这些发现为 HCC 的治疗提供了潜在靶点,因此值得进一步研究。